2022-11-11T09:01:10-06:00 2021-12-31 350921680 CROWE LLP 401 East Las Olas Blvd Suite 1100 Fort Lauderdale FL 333014230 990 2021-01-01 262117502 MAX PLANCK FLORIDA CORPORATION MAXP 5619729000 ONE MAX PLANCK WAY JUPITER FL 33458 matthias haury coo 5619729000 2022-11-11 true MATTHIAS HAURY 999009999 BRITTNEY KOCAJ P01320603 9542028600 2021 2022-09-23 18:48:47Z MAX PLANCK FLORIDA INSTITUTE FOR NEUROSCIENCE DAVID FITZPATRICK ONE MAX PLANCK WAY JUPITER FL 33458 38708457 false X https://mpfi.org/ X 2007 FL The organization's mission is to expand knowledge of the biosciences, educate and train young scientists for biomedical research and improve human welfare by applying breakthroughs in research to the advancement of medical diagnosis and medical care for the public's benefit. 17 14 170 22 0 0 21149041 21461814 316382 278093 2190247 4268061 16508 44157 23672178 26052125 0 0 13087845 13614559 0 736364 10116321 11064807 23204166 24679366 468012 1372759 109898600 113101078 1059674 1803555 108838926 111297523 The organization's mission is to expand knowledge of the biosciences, educate and train young scientists for biomedical research and improve human welfare by applying breakthroughs in research to the advancement of medical diagnosis and medical care for the public's benefit. false false 22502529 320660 Max Planck Florida Corporation established its first scientific department in the summer of 2009 and has expanded to two research divisions and six research groups to fulfill its purpose to expand knowledge of the biosciences, and educate and train young scientists for biomedical research. The eight research labs focus in the areas of disorders of neural circuit function, mechanisms of synaptic signaling and computation, functional architecture and development of cerebral cortex, development and function of inhibitory neural circuits, neuronal mechanisms of episodic memory, neuronal signal transduction, neural dynamics and cognitive functions, and neuroenergetics. (Continued on Schedule O) 22502529 true true false true false false true false true true false false false false true true false false false true false false false false false false false false true false false false false false false true false false false false false false true false false false true 20 0 true 170 true false false false false false false false false false false false false X 17 14 false false false false true true true true true false false true true true true true true true true false FL X DORIS FORCHHEIMER 5619729000 ONE MAX PLANCK WAY JUPITER FL 33458 Asifa Akhtar Chair of the Board 1.0 X X 0 0 0 David Fitzpatrick Chief Executive Officer/Scientific Director 40.0 X X 453325 0 52460 Becky Mayer Trustee 1.0 X 0 0 0 Bernard Poussot Trustee 1.0 X 0 0 0 Dirk Basting Trustee 1.0 X 0 0 0 George Elmore Trustee 1.0 X 0 0 0 Gregory Novak Trustee 1.0 X 0 0 0 James Harpel Trustee 1.0 X 0 0 0 James Weinstein Trustee 1.0 X 0 0 0 John Sculley Trustee 1.0 X 0 0 0 Kenneth Kahn Trustee 1.0 X 0 0 0 Louis Freeh Trustee 1.0 X 0 0 0 Markus Schleier Trustee 1.0 X 0 0 0 Mary Jane Panattoni Trustee 1.0 X 0 0 0 Michael Mitrione Trustee 1.0 X 0 0 0 Nasser Kazeminy Trustee 1.0 X 0 0 0 Neen Hunt Trustee 1.0 X 0 0 0 Bindumani Singh Secretary (Thru Oct 2021) 40.0 X 71281 0 31606 Doris Forchheimer VP Finance 40.0 X 176673 0 46970 Hollie Perez VP Human Relations 40.0 X 177611 0 40050 Matthias Haury Chief Operations Officer/Treasurer 40.0 X 332510 0 47706 Ryohei Yasuda Scientific Director 40.0 X 341557 0 59651 Sean Coveleski VP and Chief Development Officer 40.0 X 178021 0 28247 Idris El-Amin Head, Attending Veterinarian 40.0 X 162930 0 45921 Martha Bolton Research Group Leader 40.0 X 146112 0 32163 Naomi Kamasawa Head, Imaging & Electron Microscopy Facility 40.0 X 149318 0 36677 Sarah Stern Research Group Leader 40.0 X 169684 0 33506 Yingxue Wang Research Group Leader 40.0 X 146537 0 24997 2505559 0 479954 18 false true false Allied Universal 161 Washington Street Suite 600 Eight Tower Bridge Conshohocken PA 19428 Security 150926 1 15400658 3917679 2143477 22200 21461814 RESEARCH SERVICES/INSTRUCTION 541715 278093 278093 0 0 0 0 278093 1350069 1350069 0 0 15353028 220002 12473665 181373 2879363 38629 2917992 2917992 2884 1294 1590 1590 Other Income 900099 42567 42567 0 0 0 0 42567 26052125 320660 0 4269651 2001507 1842842 97065 61600 87723 87723 8090246 7524723 256022 309501 828420 784570 18714 25136 1920531 1762975 95843 61713 686132 636374 24549 25209 19557 19557 86333 86333 90090 90090 161363 161363 928571 928571 0 0 4470 2027 386 2057 403985 348700 21008 34277 615538 507750 63909 43879 1623736 1416094 190700 16942 32161 29718 1891 552 45926 42278 2315 1333 3293402 3067377 208137 17888 442511 351310 79458 11743 CONTRACT SERVICES & RECRUITMENT 652330 608112 28274 15944 SUPPLIES & EQUIPMENT 2505333 2429256 66745 9332 SECURITY 134511 117441 15711 1359 MISCELLANEOUS EXPENSES 24990 14688 2493 7809 0 0 0 0 24679366 22502529 1440473 736364 1143067 1268435 9041860 7981393 1909888 1611500 690495 124986 0 0 0 0 7230 10007 692237 709624 100498011 40654047 60662009 59843964 35653757 41457552 0 0 98057 93617 109898600 113101078 1059674 1803555 0 0 0 0 1059674 1803555 X 95532477 96844762 13306449 14452761 108838926 111297523 109898600 113101078 1372759 1212598 -126760 0 X false true X true true true X 20085835 21077299 20790043 21149041 21461814 104564032 0 0 20085835 21077299 20790043 21149041 21461814 104564032 0 104564032 440210 768733 752177 626136 1350039 3937295 0 0 6011 224881 17476 45451 293819 108795146 1762095 0.9611 0.3869 X Schedule A, Part II, Line 10 Other Income DESCRIPTION - VENDING INCOME, COLUMN A - 0.0, COLUMN B - 6011.0, COLUMN C - 0.0, COLUMN D - 0.0, COLUMN E - 0.0, COLUMN F - 6011.0; DESCRIPTION - MISCELLANEOUS INCOME, COLUMN A - 0.0, COLUMN B - 0.0, COLUMN C - 224881.0, COLUMN D - 17476.0, COLUMN E - 45451.0, COLUMN F - 287808.0; RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false false false false false true 90090 false false 90090 false Schedule C, Part II-B, Line 1 DETAILED DESCRIPTION OF THE LOBBYING ACTIVITY THE INSTITUTE ENGAGED A CONSULTANT TO CONDUCT LOBBYING ON ITS BEHALF. 0 32995 X false 6435282 21233 1254713 6293 7704935 5881715 12693 550276 9402 6435282 4669281 28103 1198049 13718 5881715 5072881 46426 -438341 11685 4669281 4133514 255625 695288 11546 5072881 0.0 0.52 0.48 false false 6000000 6000000 65134479 16594137 48540342 28655433 23387707 5267726 708099 672203 35896 59843964 0 X 27266017 1212598 1294 1213892 26052125 0 0 26052125 24807420 126760 1294 128054 24679366 0 0 24679366 Schedule D, Part III, Line 4 Collections of art - description of collections The organization maintains artwork in its state-of-the-art research facility as part of the building's decor. A painting in the lobby titled "Cortical Landscape" by Greg Dunn and outdoor sculpture titled "To Be Or Not To Be" by Gertrude Schweitzer. Schedule D, Part V, Line 4 Intended uses of endowment funds MAX PLANCK FLORIDA INSTITUTE FOR NEUROSCIENCE's ENDOWMENT FUND WAS ESTABLISHED FOR FUTURE GROWTH AND DEVELOPMENT OF THE INSTITUTE. THE INSTITUTE HAS ADOPTED INVESTMENT AND SPENDING POLICIES FOR ENDOWMENT ASSETS THAT ATTEMPT TO PROVIDE A PREDICTABLE STREAM OF FUNDING TO PROGRAMS SUPPORTED BY ITS ENDOWMENT WHILE SEEKING TO MAINTAIN THE PURCHASING POWER OF THE ENDOWMENT ASSETS. ENDOWMENT ASSETS INCLUDE THOSE ASSETS OF DONOR-RESTRICTED FUNDS THAT THE INSTITUTE MUST HOLD IN PERPETUITY OR FOR A DONOR-SPECIFIED PERIOD(S) AS WELL AS BOARD-DESIGNATED FUNDS. UNDER THIS POLICY, AS APPROVED BY THE BOARD OF TRUSTEES, THE ENDOWMENT ASSETS ARE INVESTED IN A MANNER OUTLINED IN THE INVESTMENT POLICY. THIS INVESTMENT POLICY'S PURPOSE IS TO PROVIDE GUIDANCE TO THE INVESTMENT MANAGERS REGARDING THE INSTITUTE'S OBJECTIVES AND GOALS WITH REGARD TO THE ENDOWMENT INVESTING. SPECIFICALLY ,IT OUTLINES THE RISK TOLERANCE AREAS OF THE INSTITUTE AS WELL AS DEFINING THE LIMITATIONS IN THE PORTFOLIO OF INVESTMENTS. THE INSTITUTE EXPECTS ITS ENDOWMENT FUNDS, OVER TIME TO PROVIDE AN AVERAGE RATE OF RETURN THAT PERMITS A PREDICTABLE AND SUSTAINABLE SPENDING RATE OF THE AVERAGE MARKET VALUE OF ENDOWMENT ASSETS BY ACHIEVING ANNUAL GROWTH IN VALUE AT A RATE EQUAL TO THE SUM OF THE ANNUAL SPENDING RATE AND THE ANNUAL RATE OF INFLATION. Schedule D, Part X, Line 2 FIN 48 (ASC 740) footnote The Organization is exempt from income taxes under Section 501(c)(3) of the Internal Revenue Code. Accordingly, no provision for income taxes is made in the accompanying financial statements. Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990 GIFT SHOP COST OF GOODS SOLD - 1294 Schedule D, Part XII, Line 2(d) Other expenses in audited financial statements not in form 990 GIFT SHOP COST OF GOODS SOLD - 1294 East Asia and the Pacific 0 0 Program Services Research Supplies, Services and Conference Travel 55010 Europe (Including Iceland and Greenland) 0 0 Program Services Research Supplies, Services and Conference Travel 303404 North America (Canada & Mexico only) 0 0 Program Services Research Supplies, Services and Conference Travel 53536 0 0 0 0 0 0 411950 0 411950 false false false false false false Schedule F, Part I, Line 3 Method used to account for expenditures on org's financial statements EAST ASIA AND THE PACIFIC-Accrual; EUROPE (INCLUDING ICELAND AND GREENLAND)-Accrual; NORTH AMERICA (CANADA & MEXICO ONLY)-Accrual X true true X X X false false false false false false false true false David Fitzpatrick Chief Executive Officer/Scientific Director 429274 0 0 0 24051 0 31550 0 20910 0 505785 0 0 0 Ryohei Yasuda Scientific Director 320887 0 0 0 20670 0 31566 0 28085 0 401208 0 0 0 Matthias Haury Chief Operations Officer/Treasurer 329828 0 0 0 2682 0 31550 0 16156 0 380216 0 0 0 Sean Coveleski VP and Chief Development Officer 177363 0 0 0 658 0 7223 0 21024 0 206268 0 0 0 Hollie Perez VP Human Relations 154702 0 2500 0 20409 0 19298 0 20752 0 217661 0 0 0 Doris Forchheimer VP Finance 172239 0 2500 0 1934 0 19298 0 27672 0 223643 0 0 0 Sarah Stern Research Group Leader 108424 0 21150 0 40110 0 7267 0 26239 0 203190 0 0 0 Idris El-Amin Head, Attending Veterinarian 161260 0 1000 0 670 0 18277 0 27644 0 208851 0 0 0 Naomi Kamasawa Head, Imaging & Electron Microscopy Facility 146658 0 1000 0 1660 0 16670 0 20007 0 185995 0 0 0 Yingxue Wang Research Group Leader 145885 0 0 0 652 0 16116 0 8881 0 171534 0 0 0 Martha Bolton Research Group Leader 144498 0 0 0 1614 0 16116 0 16047 0 178275 0 0 0 Schedule J, Part I, Line 1a First-class or charter travel the executive team travels business class when traveling overseas. In some cases the executive team travels first class when traveling domestically. Schedule J, Part I, Line 7 Non-fixed payments The organization awarded discretionary bonuses during 2021 in recognition of additional efforts made by employees in response to the COVID-19 pandemic. PAULA PARRA BUENO FAMILY MEMBER OF OFFICER MATTHIAS HAURY 76306 EMPLOYMENT false LUCAS HAURY PARRA FAMILY MEMBER OF OFFICER MATTHIAS HAURY 11417 EMPLOYMENT false Form 990, Part III, Line 4a Program Service Description (Continued from Part III) The Institute and Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. (MAX PLANCK SOCIETY FOR THE ADVANCEMENT OF SCIENCE - "Max Planck Society") have a funding agreement whereby Max Planck Society will provide annual funding for essential core scientific and administrative operations based on a mutually agreed upon budget. During 2021, the Institute received $15,400,658 from Max Planck Society, which consists of $14,468,951 for operations, $785,480 for research groups, and $146,227 for graduate programs funding. Form 990, Part VI, Line 1b Independent voting board members The three members of the Board of Trustees who are not independent are Asifa Akhtar, David Fitzpatrick and Markus Schleier. David Fitzpatrick is not independent by way of being the filing organization's President and receiving compensation from the filing organization accordingly. Asifa Akhtar and Markus Schleier are employees of Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. (MAX PLANCK SOCIETY FOR THE ADVANCEMENT OF SCIENCE - "Max Planck Society"), a foreign related organization, and are compensated by Max Planck Society accordingly. The organization is unable to secure information on compensation paid to Asifa Akhtar and Markus Schleier by Max Planck Society, after making a reasonable effort to obtain the information and is unable to provide a reasonable estimate of such compensation. Form 990, Part VI, Line 6 Classes of members or stockholders MAX PLANCK FLORIDA CORPORATION has one member, Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. (MAX PLANCK SOCIETY FOR THE ADVANCEMENT OF SCIENCE - "Max Planck Society"). Form 990, Part VI, Line 7a Members or stockholders electing members of governing body Pursuant to Section 5.3 paragraph (a) of the organization's Bylaws, the election of trustees shall take place at the annual meeting of the member (Max Planck Society.) Pursuant to Section 5.5 of the organization's Bylaws, any Trustee may be removed from office for any reason by the Member (Max Planck Society) at any regular or special meeting called for that purpose. Form 990, Part VI, Line 7b Decisions requiring approval by members or stockholders Pursuant to Section 4.5 of the Organization's bylaws, the following actions must be approved by the member (Max Planck Society): -Any change in the membership of the Corporation; -Any merger or consolidation of the Corporation with or into any other entity, or of any other entity with or into the Corporation; -Change the tax-exempt status of the Corporation; -The formation of any subsidiary entities; -Any purchase or other acquisition of assets at an aggregate cost to the Corporation in excess of Two Hundred Fifty Thousand Dollars ($250,000); -Any incurrence of loans or other indebtedness by the Corporation in an amount in excess of Twenty Thousand Dollars ($50,000); -Any amendment to the Articles of Incorporation or the Bylaws of the Corporation; -The dissolution or liquidation of the Corporation; -The authorization for the employment or discharge of any individual at the senior management level (e.g. Officers of the Corporation, Executive Team, Scientific Directors and Research Group Leaders), or for the execution and delivery of any employment, or independent contractor agreement for any employee or independent contractor whose annual base compensation exceeds One Hundred Fifty Thousand Dollars ($150,000), or the modification or termination thereof; -The entering into of any contract by the Corporation for materials or services at an aggregate contract price in excess of Two Hundred Fifty Thousand Dollars ($250,000); -The creation of any indebtedness or any other obligation of the Corporation in excess of Fifty Thousand Dollars ($50,000); -The compensation to be paid to Trustees or committee members; -Any decision affecting the filing of corporate tax returns or the handling of corporate tax matters; and -The appointment of any Professor or Associate Professor to any institute developed or maintained by the Corporation. In addition, two of the trustee positions shall be reserved for representatives of Max Planck Society. Form 990, Part VI, Line 11b Review of form 990 by governing body The governing body reviews Form 990 and the related schedules along with the audit committee and management. These individuals review the Form 990, prepared by an outside CPA, in its entirety prior to filing with the Internal Revenue Service and communicate to the Board of Trustees at the next scheduled board meeting. This approval process is documented with the signature of the COO or CEO. Form 990, Part VI, Line 12c Conflict of interest policy The organization regularly and consistently monitors compliance with the Conflict of Interest policy by annually distributing Conflict of Interest forms to interested persons to complete. Completed forms are first reviewed by the organization's Secretary for any relationships or transactions that may need to be disclosed to the Board of Trustees. Conflicts that arise must be reported to the board whereby appropriate action is taken. Form 990, Part VI, Line 15a Process to establish compensation of top management official Independent data is used to establish compensation for every key management position prior to and at the time of hire. The Board of Trustees ratifies hires at the next scheduled board meeting. The compensation committee along with all senior officers participate in hiring, review, and decision. The compensation committee meets annually to review CEO compensation. The compensation committee uses industry statistics, benchmarking data, and surveys for comparability purposes. This process was last undertaken in 2021. Form 990, Part VI, Line 15b Process to establish compensation of other employees Independent data is used to establish compensation for every key management position prior to and at the time of hire. The Board of Trustees ratifies hires at the next scheduled board meeting. The compensation committee along with all senior officers participate in hiring, review, and decision. The compensation committee meets annually to review compensation of other officers. The compensation committee uses industry statistics, benchmarking data, and surveys for comparability purposes when reviewing officer compensation, and the compensation committee and Board of Trustees approves compensation of all other officers. This process was last undertaken in 2021. Form 990, Part VI, Line 19 Required documents available to the public Financial statements, governing documents, and conflict of interest policies are not required disclosures pursuant to Internal Revenue Code (IRC) Section 6104. These documents are not available to the public at this time. Form 990, Part VII, Section A Line 1 - Compensation of Directors by Related Organizations The organization is unable to secure information on compensation paid to Asifa Akhtar and Markus Schleier by the foreign related organization, Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V. (MAX PLANCK SOCIETY FOR THE ADVANCEMENT OF SCIENCE - "Max Planck Society"), after making a reasonable effort to obtain the information and is unable to provide a reasonable estimate of such compensation. The organization has had discussions with multiple legal teams representing the Max Planck Society, who have confirmed that this compensation information will not be provided for purposes of the Max Planck Florida Corporation Form 990 due to privacy laws in Germany. Max-Planck-Gesellschaft zur Foerderung der Wissenschaften eV Research GM 501(c)(3) NA false false false true false false false false false false false false false false false false false false false false